Huntsworth plc has announced that Annabelle Sandeman has been appointed its new global head of commercial strategy. Sandeman has more than 20 years of experience in the industry and has held leading roles at Huntsworth Health across all agency disciplines, spanning a breadth of therapeutic categories and stakeholders around the world. Prior to joining Huntsworth, Annabelle held an in-house role at AbbVie.

Sandeman’s promotion to this new role aligns with Huntsworth’s growth strategy, which is focused on global healthcare. She will be working directly with leadership teams across Huntsworth Health and Huntsworth Communications to introduce new product offerings, access new markets and geographies, as well as continue to build key relationships with clients and procurement worldwide.

“The fast moving and increasingly specialised environment for prescription medicines has led to an increasing client demand for new and complementary services to support their near-and longer-term growth ambitions,” says Sandeman. “Huntsworth has a strong track record of growth and innovation, and with the strengths and flexibility of our key healthcare agencies Medistrava, Evoke and TCEG, we are well positioned to evolve even more quickly.”

Huntsworth CEO Paul Taaffe, adds, “Over the last couple of years, Huntsworth has placed more and more emphasis on serving its healthcare clients. This new role is a further key step to rapidly adapt to meeting the changing needs of our clients as they look to benefit from the current exciting developments happening in medicine. Annabelle is a healthcare expert, having worked across all disciplines, geographies and markets, and I am confident that her skills will play an important role in enabling Huntsworth to achieve our growth targets.”

During her time at Huntsworth Health, Sandeman has led its medical and PR teams and worked within its creative agencies. She is also co-chair of the Communique awards in 2019 and on the governance committee for the Healthcare Communications Association (HCA).